Radiopharmacutial 1 F18-florbetapir neuraceq per unit dose
Active Blanket Purchase Agreement Awarded Last action
- Contract number
- 36C24925A0046
- Awardee
-
Pharmalogic Holdings Corp. UEI HVFXH4DBMXF2
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 3 $1,020,175 obligated
Award facts
- Opportunity
-
- 6525--Nuclear Medicine NEURACEQ F-18 FLORBETABEN PET DEP Solicitation · 36C24925Q0157 · Posted Feb 23, 2025
- Combined order value
-
- $1,020,175 Current, with exercised options
- $1,886,625 Potential, with all options
- Last date to order 32% complete
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
Veterans Integrated Service Network 9 awarded a Blanket Purchase Agreement to Pharmalogic Holdings Corp. on March 15, 2025, with a ceiling of $978,250.00 for the supply of F18-florbetapir (NeuraCeq) radiopharmaceutical unit doses through March 14, 2030.
The BPA is designated as a total small business set-away under NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing). Place of performance is Lexington, Kentucky, where radiopharmaceutical products are delivered to the VA Medical Center to support nuclear medicine and PET diagnostic imaging for veteran patient care.
The underlying solicitation required supply of F18-florbetapir doses compliant with federal regulations for medical byproducts, with evaluation based on price, technical capability to meet turnaround times, and past performance. The base contract and four option years span from March 15, 2025, through March 14, 2030, with increasing annual unit-dose quantities: 40 doses in year one, scaling to 100 doses by year five, for a total of 350 doses over the performance period.
Two BPA calls have been issued under this vehicle. A call awarded October 1, 2025, carries a $279,500.00 ceiling through March 14, 2030, with fixed-price-with-economic-price-adjustment pricing. A second call awarded March 15, 2026, carries a $628,875.00 ceiling through March 14, 2030, also using fixed-price-with-economic-price-adjustment pricing, with place of performance at Lexington, Kentucky.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Radiopharmacutial 1 F18-florbetapir neuraceq per unit dose | Veterans Integrated Service Network 9 (VHA) | $628,875 | |
| Radiopharmacutial 1 F18-florbetapir neuraceq per unit dose | Veterans Integrated Service Network 9 (VHA) | $279,500 | |
| Radiopharmacutial 1 F18-florbetapir neuraceq per unit dose | Veterans Integrated Service Network 9 (VHA) | $111,800 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36C24925A0046?
36C24925A0046 was awarded to Pharmalogic Holdings Corp. by Veterans Integrated Service Network 9 (Veterans Health Administration) on March 15, 2025.
How much is contract 36C24925A0046 worth?
Orders under 36C24925A0046 have obligated $1,020,175. Their combined potential value, with all options, is $1,886,625.
How many orders have been placed under contract 36C24925A0046?
3 orders have been placed under 36C24925A0046, the latest on March 15, 2026.
Who can order from contract 36C24925A0046?
36C24925A0046 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV